APPLICATION OF ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY

Year : 2025 | Volume : 12 | Issue : 03 | Page : 22 29
    By

    Gaurang Rai,

  1. Student, Department of Computer Science and Engineering (CSE), Vellore Institute of Technology, Bhopal University, Bhopal-Indore Highway, Kothrikalan, Sehore, Madhya Pradesh, India

Abstract

The application of artificial intelligence (AI) in medicine, especially through machine learning (ML), is revolutionizing new-age drug discovery research. AI is found as an efficient and powerful tool to narrow the gap between disease detection and developing and identifying potential therapeutic agents for a cure. This review provides a summary of the latest developments in AI and its potential application in drug discovery for untreatable diseases. The review also examines the various basic stages of the drug discovery process, like (a) disease identification, (b) disease proper diagnosis, (c) target identification, (d) screening, and (e) drug discovery. AI’s application will greatly help to analyze huge datasets and discern patterns, which is essential in these early stages of drug discovery. Thus, enhancing accurate predictions and efficiencies in disease identification and most suitable drug discovery, followed by clinical trial management. In this review, the role of AI in expediting drug development work is highlighted, and its great potential to analyze huge historical data volumes, which will significantly reduce the time and costs required for new drug development and its market introduction. The need for data quality, algorithm training, and ethical considerations, especially in patient data handling during clinical trials during drug discovery development work using AI, is emphasized. Considering above-mentioned factors, AI seems to be capable of transforming drug development and assures significant benefits to patients and society globally, which is a great support to humanity.

Keywords: Artificial intelligence, machine learning, disease identification, drug design, drug discovery

[This article belongs to Emerging Trends in Chemical Engineering ]

How to cite this article:
Gaurang Rai. APPLICATION OF ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY. Emerging Trends in Chemical Engineering. 2025; 12(03):22-29.
How to cite this URL:
Gaurang Rai. APPLICATION OF ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY. Emerging Trends in Chemical Engineering. 2025; 12(03):22-29. Available from: https://journals.stmjournals.com/etce/article=2025/view=233283


References

1. Vamathevan J, Clark D, Czodrowski P, et al. Applications of machine learning in drug discovery and development. Nat Rev Drug Discov. 2019; 18(6): 463–477.
2. Zhavoronkov A, Ivanenkov YA, Aliper A, et al. Deep learning enables rapid identification of potent DDR1 kinase inhibitors. Nat Biotechnol. 2019; 37(9): 1038–1040.
3. Jumper J, Evans R, Pritzel A, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021; 596(7873): 583–589.
4. Chen H, Engkvist O, Wang Y, Olivecrona M, Blaschke T. The rise of deep learning in drug discovery. Drug Discovery Today. 2018; 23(6): 1241–1250.
5. Hinkson IV, Madej B, Stahlberg EA. Accelerating therapeutics for opportunities in medicine: A paradigm shift in drug discovery Front Pharmacol. 2020; 11: 770.
6. Barker R. A flexible blueprint for the future of drug development. Lancet. 2010; 375(9712): 357–359.
7. Sun D, Gao W, Hu H, et al. Why 90% of clinical drug development fails and how to improve it? Acta Pharm Sin B. 2022; 12(7): 3049–3062.
8. Hassanzadeh P, Atyabi F, Dinarvand R. The significance of artificial intelligence in drug delivery system design. Adv Drug Deliv Rev. 2019; 151–152: 169–190.
9. Bolcer JD, Hermann RB. The development of computational chemistry in the United States. Rev Comput Chem. Vol. 5. Wiley; 1994; 1–63.
10. Bianconi F, Filippucci M. Digital Wood Design: Innovative Techniques of Representation in Architectural Design. Vol. 24. Cham: Springer; 2019.
11. Ding Y, Sohn JH, Kawczynski MG, et al. A deep learning model to predict a diagnosis of Alzheimer disease by using 18F-FDG PET of the brain. Radiology. 2019; 290(2): 456–464.
12. Narin A, Kaya C, Pamuk Z. Automatic detection of coronavirus disease (covid-19) using x-ray images and deep convolutional neural networks. Pattern Anal Appl. 2021; 24(3): 1207–1220.
13. Gentile F, Yaacoub JC, Gleave J, et al. Artificial intelligence–enabled virtual screening of ultra-large chemical libraries with deep docking. Nat Protoc. 2022; 17(3): 672–697.
14. Carpenter KA, Cohen DS, Jarrell JT, et al. Deep learning and virtual drug screening. Future Med Chem. 2018; 10(21): 2557–2567.
15. Bule M, Jalalimanesh N, Bayrami Z, et al. The rise of deep learning and transformations in bioactivity prediction power of molecular modeling tools. Chem Biol Drug Des. 2021; 98(5): 954–967.
16. Berzuini C, Bellazzi R, Quaglini S, et al. Bayesian networks for patient monitoring. Artif Intell Med. 1992; 4(3): 243–260.
17. Kapsiani S, Howlin BJ. Random forest classification for predicting lifespan-extending chemical compounds. Sci Rep. 2021; 11(1): 13812(13p).
18. Heikamp K, Bajorath J. Support vector machines for drug discovery. Expert Opin Drug Discov. 2014; 9(1): 93–104.
19. Paul D, Sanap G, Shenoy S, Kalyane D, Kalia K, Tekade RK. Artificial intelligence in drug discovery and development. Drug Discov Today. 2021; 26(1): 80–93. doi: 10.1016/j.drudis.2020.10.010
20. Xu Y, Liu X, Cao X, Huang C, Liu E, Qian S, Liu X, Wu Y, Dong F, Qiu CW, et al. Artificial intelligence: A powerful paradigm for scientific research. Innovation. 2021; 2(4): 100179. doi: 10.1016/j.xinn.2021.100179.
21. Zhuang D, Ibrahim AK. Deep learning for drug discovery: A study of identifying high efficacy drug compounds using a cascade transfer learning approach. Appl Sci. 2021; 11(17): 7772. doi: 10.3390/app11177772
22. Pu L, Naderi M, Liu T, Wu HC, Mukhopadhyay S, Brylinski M. EToxPred: A machine learning-based approach to estimate the toxicity of drug candidates. BMC Pharmacol Toxicol. 2019; 20(1): 2. doi: 10.1186/s40360-018-0282-6.
23. Rees C. The ethics of artificial intelligence. In: Strous L, Johnson R, Grier DA, Swade D, editors. Unimagined Futures – ICT Opportunities and Challenges. Cham: Springer; 2020. (IFIP Advances in Information and Communication Technology; vol. 555). doi:10.1007/978-3-030-64246-4_5.
24. Abou Hajal A, Al Meslamani AZ. Insights into artificial intelligence utilisation in drug discovery. J Med Econ. 2024; 27(1): 304–8.
25. Hopkins AL, Groom CR. The druggable genome. Nat Rev Drug Discov. 2002; 1(9): 727–30.
26. Lin Q, Tam PK-H, Tang CS-M. Artificial intelligence-based approaches for the detection and prioritization of genomic mutations in congenital surgical diseases. Front Pediatr. 2023; 11: 1203289.
27. Overington JP, Al-Lazikani B, Hopkins AL. How many drug targets are there? Nat Rev Drug Discov. 2006; 5(12): 993–6.
28. Knox C, et al. DrugBank 6.0: the DrugBank Knowledgebase for 2024. Nucleic Acids Res. 2024; 52(D1): 1265–d1275.
29. Kim S, et al. PubChem 2025 update. Nucleic Acids Res. 2024; 53(D1): D1516–25.
30. Lv J, et al. ACDB: an antibiotic combination database. Front Pharmacol. 2022; 13: 869983.
31. Lv J, et al. AADB: a manually collected database for combinations of antibiotics with adjuvants. IEEE/ACM Trans Comput Biol Bioinf. 2023; 20(5): 2827–36.
32. Chen W, et al. Artificial intelligence for drug discovery: resources, methods, and applications. Mol Ther Nucleic Acids. 2023; 31: 691–702.
33. Qiu X, et al. Advances in AI for protein structure prediction: implications for cancer drug discovery and development. Biomolecules. 2024; 14(3): 339.
34. Serrano DR, et al. Artificial intelligence (AI) applications in drug discovery and drug delivery: revolutionizing personalized medicine. Pharmaceutics. 2024; 16(10): 1328.
35. Osama S, Shaban H, Ali AA. Gene reduction and machine learning algorithms for cancer classification based on microarray gene expression data: a comprehensive review. Expert Syst Appl. 2023; 213: 118946.
36. Statnikov A, et al. A comprehensive evaluation of multicategory classification methods for microarray gene expression cancer diagnosis. Bioinformatics. 2005; 21(5): 631–43.
37. Friedman J. The elements of statistical learning: data mining, inference, and prediction. New York, NY: Springer; 2009.
38. Ching T, et al. Opportunities and obstacles for deep learning in biology and medicine. J R Soc Interface. 2018; 15(141): 20170387.
39. Boby ML, et al. Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors. Science. 2023; 382(6671): 201.
40. Shen M-Y, et al. A comprehensive support vector machine binary hERG classification model based on extensive but biased end point hERG data sets. Chem Res Toxicol. 2011; 24(6): 934–49.
41. Hassanzadeh P. The significance of artificial intelligence in drug delivery system design. Adv Drug Delivery Rev. 2019; 151–152: 169–190. doi: 10.1016/j.addr.2019.05.001
42. Luo . icro‐/nanorobots at work in active dru delivery. dv Funct Mater. 2018; 28(25): 1706100.
43. Fu J, Yan H. Controlled drug release by a nanorobot. Nat Biotechnol. 2012; 30(5): 407–408. doi: 10.1038/nbt.2206
44. Calzolari D. Search algorithms as a framework for the optimization of drug combinations. PLoS Comput Biol. 2008; 4(12): e1000249. doi: 10.1371/journal.pcbi.1000249.
45. Wilson B, KM. Artificial intelligence and related technologies enabled nanomedicine for advanced cancer treatment. Nanomedicine (Lond). 2020;15(5):433–5. doi:10.2217/nnm-2019-0366. PubMed: 31997697.
46. Tsigelny IF. Artificial intelligence in drug combination therapy. Brief Bioinform. 2019; 20(4): 1434–1448. doi: 10.1093/bib/bby004
47. Insilico. (2023 Jan 10). A Phase 1 Breakthrough in AI Drug Discovery. [Online]. https://insilico.com/blog/ipf-phase1#:~:text=The%20safety%20and%20PK%20data,in%20 drug%20discovery%20and%20development.
48. AlphaFold Protein Structure Database. [Online]. https://alphafold.ebi.ac.uk/
49. Benevolent AI. (2022 Apr 25). AI-Enabled Drug Discovery. [Online]. https://www.benevolent.com/news-and-media/blog-and-videos/benevolentai-ai-enabled-drug-discovery/
50. Chirag Bhardwaj. (2025 Jul 17). The Potential of AI in Drug Discovery and its Impact on Healthcare. [Online]. https://appinventiv.com/blog/ai-in-drug-discovery/
51. DrugBank Team. (2024 Apr 12). Unleashing AI in Drug Discovery: Prospects and Challenges. [Online]. https://blog.drugbank.com/unleashing-ai-in-drug-discovery-prospects-and-challenges/

Regular Issue Subscription Review Article
Volume 12
Issue 03
Received 20/07/2025
Accepted 31/08/2025
Published 17/09/2025
Publication Time 59 Days
207

Login


My IP

PlumX Metrics